BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  VitriVax Receives Grant From the Coalition for Epidemic Preparedness Innovations (CEPI) to Leverage ALTA® Technology for Single-Dose Rabies Vaccine

  April 29, 2025

   · 

  2 min read
• Press Releases

  enGene to Participate in Upcoming May 2025 Investor Conferences

  April 29, 2025

   · 

  1 min read
• Press Releases

  Study Published in Advanced Science Demonstrates Scale, Resolution and Accuracy of Corticale SiNAPS Technology for Next-generation Brain-Computer Interfaces

  April 29, 2025

   · 

  5 min read
• Press Releases

  Unmatched Long-Term Bladder Preservation for 36 Months in over 80 percent of Responders with ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC CIS and Papillary Disease Alone – Best in Disease and Best in Class with 5 Year Follow-Up

  April 29, 2025

   · 

  12 min read
• Press Releases

  KOLON TISSUEGENE HIGHLIGHTS LONG-TERM SAFETY DATA AND POTENTIAL U.S. FDA PATHWAY FOR TG-C AT OARSI WORLD CONGRESS

  April 29, 2025

   · 

  4 min read
• Press Releases

  Scribe Achieves Milestone for In Vivo Program in Collaboration with Prevail Therapeutics, a part of Lilly’s Gene Therapy Division, and Announces ASGCT Joint Presentation on Self-Inactivating AAV Technology for Neurological and Neuromuscular Disorders

  April 29, 2025

   · 

  3 min read
• Press Releases

  Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

  April 29, 2025

   · 

  1 min read
• Press Releases

  AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening

  April 29, 2025

   · 

  4 min read
• Press Releases

  Nature Communications Medicine Publishes Positive, Real World Data for Tinnitus Patients Treated with Unique, FDA Approved Stimulation Device

  April 29, 2025

   · 

  7 min read
• Press Releases

  Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium

  April 29, 2025

   · 

  8 min read